title: Mechanisms underlying neurocognitive dysfunctions in recurrent major depression.
abstract: Recent work shows that depression is intimately associated with changes in cognitive functioning, including memory, attention, verbal fluency, and other aspects of higher-order cognitive processing. Changes in cognitive functioning are more likely to occur when depressive episodes are recurrent and to abate to some degree during periods of remission. However, with accumulating frequency and duration of depressive episodes, cognitive deficits can become enduring, being evident even when mood improves. Such changes in cognitive functioning give depression links to mild cognitive impairment and thereby with neurodegenerative conditions, including Alzheimer's disease, Parkinson's disease, schizophrenia, and multiple sclerosis. Depression may then be conceptualized on a dimension of depression - mild cognitive impairment - dementia. The biological underpinnings of depression have substantial overlaps with those of neurodegenerative conditions, including reduced neurogenesis, increased apoptosis, reactive oxygen species, tryptophan catabolites, autoimmunity, and immune-inflammatory processes, as well as decreased antioxidant defenses. These evolving changes over the course of depressive episodes drive the association of depression with neurodegenerative conditions. As such, the changes in cognitive functioning in depression have important consequences for the treatment of depression and in reconceptualizing the role of depression in wider neuroprogressive conditions. Here we review the data on changes in cognitive functioning in recurrent major depression and their association with other central conditions.
authors.affiliation: Department of Adult Psychiatry, Medical University of Łódź, Łódź, Poland.
authors.forename: Piotr
authors.initials: P
authors.lastname: Gałecki
authors.affiliation: Department of Adult Psychiatry, Medical University of Łódź, Łódź, Poland.
authors.forename: Monika
authors.initials: M
authors.lastname: Talarowska
authors.affiliation: CRC Scotland & London, London, United Kingdom.
authors.forename: George
authors.initials: G
authors.lastname: Anderson
authors.affiliation: Orygen Research Centre, Parkville, VIC, Australia.
authors.forename: Michael
authors.initials: M
authors.lastname: Berk
authors.affiliation: IMPACT Strategic Research Centre, Deakin University, Geelong, VIC, Australia.
authors.forename: Michael
authors.initials: M
authors.lastname: Maes
mesh_terms: D017209:Apoptosis / Q000502:physiology; D001288:Attention / Q000502:physiology*; D002940:Circadian Rhythm / Q000502:physiology*; D003865:Major Depressive Disorder / Q000150:complications*; D056344:Executive Function / Q000502:physiology*; D006801:Humans; D007030:Hypothalamo-Hypophyseal System / Q000502:physiology; D007249:Inflammation / Q000209:etiology / Q000503:physiopathology*; D008568:Memory / Q000502:physiology*; D019965:Neurocognitive Disorders / Q000209:etiology / Q000503:physiopathology*; D055495:Neurogenesis / Q000502:physiology*; D018384:Oxidative Stress / Q000502:physiology; D010913:Pituitary-Adrenal System / Q000502:physiology; D011597:Psychomotor Performance / Q000502:physiology; D017382:Reactive Oxygen Species / Q000378:metabolism; D014364:Tryptophan / Q000378:metabolism
chemical_list: D017382:Reactive Oxygen Species; D014364:Tryptophan